Paediatric Respiratory Reviews
Volume 11, Issue 1 , Pages 39-45 , March 2010

Acute viral bronchiolitis in children- a very common condition with few therapeutic options

References 

  1. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997–2000. J Pediatr. 2003;143:S127–S132
  2. Deshpande S, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child. 2003;88:1065–1069
  3. Mallory M, Shay D, Garrett J, et al. Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics. 2003;111(1):pe45–e51
  4. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344(25):1917–1928
  5. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus (RSV) infection. Arch Dis Child. 2009;94(2):99–103
  6. Fleming D, Pannell R, Cross K. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health. 2005;59:586–590
  7. Thompson W, Shay D, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–186
  8. Fjaerli H-O, Farstad T, Rod G, et al. Acute bronchiolitis in infancy as a risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatrics. 2005;5:
  9. Bisgaard H, Florez-Nunez A, Goh A, et al. Study of Montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008;178:854–860
  10. Plint A, Johnson D, Wiebe N, et al. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emer Med. 2004;11:353–360
  11. Gadomski, AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database of Systematic Reviews, 2006 (Issue 3).
  12. Patel, H., Platt R, Lozano JM, et al. Glucocorticoids for acute viral bronchiolitis in infants in infants and young children. (Review). Cochrane Database of Systematic Reviews, 2007 (Issue 4).
  13. Halfhide C, Smyth RL. Innate immune response and bronchiolitis and preschool recurrent wheeze. Paediatric Respiratory Reviews. 2008;9:251–262
  14. Semple MG, Dankert HM, Ebrahimi B, et al. Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon-gamma and substance P. PLoS ONE. 2007;2(10):pe1038
  15. Groskreutz D, Monick M, Yarovinsky T, et al. RSV decreases p53 protein tp prolong survival of airway epithelial cells. J Immunol. 2007;179:2741–2747
  16. Papadopoulos NG, Moustaki M, Tsolia M, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002;165:1285–1289
  17. Xepapadaki P, Psarras S, Bossios A, et al. Human Metapneumovirus as a causative agent of acute bronchiotis in infants. J Clin Virol. 2004;30:267–270
  18. Jacques J, Moret H, Renois F, et al. Human Bocavirus quantitative DNA detection in French children hoispitalized for acute bronchiolitis. J Clin Virol. 2008;43:142–147
  19. Marguet C, Lubrano M, Gueudin M, et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS ONE. 2009;4:pe4596
  20. Semple MG, Cowell A, Dove W, et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis. 2005;191:382–386
  21. Garcia-Garcia M, Calvo C, Perez-Brena P, et al. Prevalence and clinical characteristics of human metapneumovirus infections in hospitalized infants in Spain. Pediatr Pulmonol. 2006;41:863–871
  22. Papadopoulos NG, Gourgiotis D, Javadyan A, et al. Does respiratory syncytial virus subtype influence the severity of acute bronchiolitis in hospitalized infants. Respir Med. 2004;98:879–882
  23. Fodha I, Vabret A, Ghedira L, et al. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. J Med Virol. 2007;79:1951–1958
  24. Gerna G, Campanini G, Rognoni V, et al. Correlation of viral load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy. J Clin Virol. 2008;41:45–48
  25. Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med. 2002;156:322–324
  26. Thorburn K, Harigopal S, Reddy V, et al. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax. 2006;61:611–615
  27. Nakamura A, Sakano T, Nakayama T, et al. Neonatal pertussis presenting as acute bronchiolitis:direct detection of the Bordetella pertussis genome using loop-mediated isothermal amplification. Eur J Pediatr. 2009;168:347–349
  28. Sung RY, Chan RC, Tam JS, et al. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants. Epidemiol Infect. 1992;108:147–154
  29. Kahane S, Greenberg D, Friedman MG, et al. High prevalence of “Simkania Z” a novel Chlamydia-like bacterium, in infants with acute bronchiolitis. J Infect Dis. 1998;177:1425–1429
  30. Woo PCY, Chiu SS, Seto W-H, et al. Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients. J Clin Microbiol. 1997;35:1579–1581
  31. Hall CB, Douglas RG, Schnabel K, et al. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun. 1981;33:779–783
  32. Falsey AR, Formica MA, Treanor JJ, et al. Comparison of quantitative reverse trasncription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol. 2003;41:4160–4165
  33. Koehoorn M, Karr CJ, Demers PA, et al. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics. 2008;122:1196–1203
  34. Kneyber MCJ, Steyerberg EW, de Groot R, et al. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr. 2000;89:654–660
  35. Moore H, Burgner D, Carville K, et al. Diverging trends for lower respiratory infections in non-Aboriginal and Aboriginal children. J Paediatr Child Health. 2007;43:451–457
  36. Grimwood K, Cohet C, Rich FJ, et al. Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. Epidemiol Infect. 2008;136(10):1333–1341
  37. Heikkinen T, Valkonen H, Lehtonen L, et al. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivivizumab prophylaxis. Arch Dis Child Fetal Neonatal Ed. 2005;90:F64–F68
  38. Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic neonatal lung disease, related to hospitalisation for RSV infection. Arch Dis Child. 2001;85:463–468
  39. Eriksson M, Bennet R, Rotzen-Ostlund M, et al. Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr. 2002;91(5):593–598
  40. Chatzimichael , Tsalkidis AA, Cassimos D, et al. The role of breastfeeding and passive smoking on the development of severe bronchiolitis in infants. Minerva Pediatr. 2007;59(3):199–206
  41. Holberg CJ, Wright AL, Martinez FD, et al. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol. 1991;133:1135–1151
  42. Spencer N, Logan S, Scholey S, et al. Deprivation and bronchiolitis. Arch Dis Child. 1996;74:50–52
  43. Parker MJ, Allen U, Stephens D, et al. Predictors of major intervention in infants with bronchiolitis. Pediatr Pulmonol. 2009;44(4):358–363
  44. Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr. 2009;154:91–95
  45. Viswanathan, M., King VJ, Bordley C, et al., Management of bronchiolitis in infants and children. Evidence Report/Technology Assessment No 69 (Prepared by RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center under Contract N0. 290-97-0011). in AHRQ Publication No. 03-E014. 2003, Department of Heath and Human Services, Agency for Healthcare Research and Quality: Rockville (MD).
  46. Cheney J, Barber S, Altamirano L, et al. A clinical pathway for bronchiolitis is effective in reducing readmission rates. J Pediatr. 2005;147:622–626
  47. Unger S, Cunningham S. Effect of oxygen supplementation on length of stay for infants hospitalized with acute viral bronchiolitis. Pediatrics. 2008;121:470–475
  48. Babl FE, Sheriff N, Neutze J, et al. Bronchiolitis management in pediatric emergency departments in Australia and New Zealand: a PREDICT study. Pediatr Emerg Care. 2008;24:656–658
  49. Hartling, Wiebe LN, Russell KF, et al., Epinephrine for bronchiolitis. Cochrane Database of Systematic Reviews, 2004 (Issue 1).
  50. Blom, D.J.M., Ermers M, Bont L, et al., Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database of Systematic Reviews, 2007 (Issue 1).
  51. Plint AC, Johnson DW, Patel H, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009;360:2079–2089
  52. Zhang, L., Mendoza-Sassi RA, Wainwright C, et al., Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews, 2008 (Issue 4)
  53. Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J. 2007;29:91–97
  54. Kneyber MCJ, Van Woensel JBM, Uijtendaal E, et al. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: A randomized equivalence trial. Pediatr Pulmonol. 2008;43:142–149
  55. Amirav I, Luder AS, Kruger N, et al. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. Pediatrics. 2008;122:e1249–1255
  56. Perrotta, C., Ortiz Z, Roque i Figuls M, Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months ol. Cochrane Database of Systematic Reviews, 2007 (Issue1).
  57. Javouhey E, Barats A, Richard N, et al. Non-invasive ventilation as primary ventilatory support for infants with severe bronchiolitis. Intensive Care Med. 2008;34(9):1608–1614
  58. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Nasal continuous positive airway pressure with heliox versus air oxygen in infants with acute bronchiolitis: a crossover study. Pediatrics. 2008;121(5):e1190–1195
  59. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high risk infants. Pediatrics. 1998;102(3 Pt 1):531–537
  60. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003;143:532–540
  61. Swingler GH, Hussey GD, Zwarenstein M. Duration of illness in ambulatory children diagnosed with bronchiolitis. Arch Pediatr Adolesc Med. 2000;154:997–1000
  62. Perez-Yarza E, Moreno A, Lazaro P, et al. The association between RSV infection and development of childhood asthma. Paediatr Infect Dis J. 2007;26:733–739

PII: S1526-0542(09)00069-4

doi: 10.1016/j.prrv.2009.10.001

Paediatric Respiratory Reviews
Volume 11, Issue 1 , Pages 39-45 , March 2010

Article Tools